(Salicylato)[tris­(1-methyl-1H-benz­imidazol-2-ylmeth­yl)amine]copper(II) perchlorate dimethyl­formamide disolvate

In the title complex, [Cu(C(7)H(5)O(3))(C(27)H(27)N(7))]ClO(4)·2C(3)H(7)NO, the Cu(II) ion is five-coordinated by four N atoms from the tris­(1-methyl-1H-benzimidazol-2-ylmeth­yl)amine ligand and an O atom of the monodentate salicylate ligand. The N(4)O donor set defines a coordination geometry inter­mediate between square-pyramidal and trigonal–bipyramidal. The crystal structure is stabilized by O—H⋯O inter­actions. The atoms of the aromatic ring of the salicylate ligand are disordered over two sites of equal occupancy. In addition, one of the dimethyl­formamide solvent mol­ecules is partially disordered over two positions, of approximately equal occupancy.